Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma

Ina Hornemann Borg1, Mette Dahl Bendtsen1,2, Martin Bøgsted1,3

  • 1a Department of Hematology , Aalborg University Hospital , Aalborg , Denmark.

Leukemia & Lymphoma
|June 9, 2016
PubMed

Insights

Venous thromboembolism (VTE) affects 11% of diffuse large B-cell lymphoma (DLBCL) patients. Prior VTE, performance status, and disease stage are key risk factors for VTE in DLBCL.

Area of Science:

  • Hematology
  • Oncology
  • Clinical Research

Background:

  • Venous thromboembolism (VTE) is a significant complication in patients diagnosed with diffuse large B-cell lymphoma (DLBCL).
  • Understanding VTE risk factors and diagnostic accuracy is crucial for managing DLBCL patients.

Purpose of the Study:

  • To evaluate the incidence of VTE in a cohort of DLBCL patients.
  • To identify risk factors associated with VTE development in DLBCL.
  • To assess the quality of VTE discharge diagnoses recorded in patient registries.

Main Methods:

  • Retrospective cohort study of DLBCL patients from 2007-2013 at Aalborg University Hospital.
  • Medical record review to identify confirmed VTE events over two years.
  • Cox regression analysis to determine VTE risk factors.
  • Comparison of registry diagnoses with medical records for data quality assessment.

Main Results:

  • Eleven percent of DLBCL patients were diagnosed with VTE.
  • Significant associations found between VTE and prior VTE, performance status, and Ann Arbor stage.
  • The positive predictive value for VTE discharge diagnosis was 85%, with a sensitivity of 53%.

Conclusions:

  • VTE is a common complication in DLBCL patients, influenced by disease stage and patient factors.
  • While registry diagnoses have a high positive predictive value, their sensitivity is limited, highlighting potential underdiagnosis.
  • Improved diagnostic strategies and risk stratification are needed for VTE in DLBCL.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
422
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
642
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
456
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
363
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
10.1K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.5K